This parallel-design double-blind trial examines the efficacy and safety of the heat shock protein 90 inhibitor RGRN-305 in patients with hidradenitis suppurativa.
All Keywords
Communicable Diseases Research
감염병 연구데이터
This parallel-design double-blind trial examines the efficacy and safety of the heat shock protein 90 inhibitor RGRN-305 in patients with hidradenitis suppurativa.